Cargando…
Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives
Globally, lung cancer is the most commonly diagnosed cancer and carries with it the greatest mortality rate, with 5-year survival rates varying from 4–17% depending on stage and geographical differences. For decades, researchers have studied disease mechanisms, occurrence rates and disease developme...
Autores principales: | Chen, Huan-Huan, Zhang, Tie-Ning, Wu, Qi-Jun, Huang, Xin-Mei, Zhao, Yu-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290158/ https://www.ncbi.nlm.nih.gov/pubmed/34295810 http://dx.doi.org/10.3389/fonc.2021.664290 |
Ejemplares similares
-
The function and clinical implication of circular RNAs in lung cancer
por: Ren, Wenjun, et al.
Publicado: (2022) -
Circular RNAs in hepatocellular carcinoma: Recent advances
por: Niu, Zhao-Shan, et al.
Publicado: (2022) -
Recent advances in understanding circular RNAs
por: Ebermann, Constanze, et al.
Publicado: (2020) -
The Role of Circular RNAs in the Drug Resistance of Cancers
por: Liu, Xin-Yuan, et al.
Publicado: (2022) -
Emerging Role of Circular RNAs in Cancer
por: Liu, Jing, et al.
Publicado: (2020)